Myriam Curet Sells 105 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 105 shares of Intuitive Surgical stock in a transaction on Monday, November 10th. The shares were sold at an average price of $560.00, for a total transaction of $58,800.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Tuesday, October 28th, Myriam Curet sold 7,562 shares of Intuitive Surgical stock. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66.
• On Wednesday, October 29th, Myriam Curet sold 125 shares of Intuitive Surgical stock. The stock was sold at an average price of $543.00, for a total value of $67,875.00.

Intuitive Surgical Stock Performance

ISRG opened at $565.51 on Friday. The company has a market cap of $202.72 billion, a PE ratio of 74.80, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. The stock has a 50-day moving average of $480.86 and a 200-day moving average of $502.93. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.84 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its stake in shares of Intuitive Surgical by 0.8% in the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after purchasing an additional 263,828 shares in the last quarter. State Street Corp increased its holdings in Intuitive Surgical by 1.2% in the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after buying an additional 182,871 shares during the period. Geode Capital Management LLC raised its stake in shares of Intuitive Surgical by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after buying an additional 109,904 shares in the last quarter. Capital World Investors raised its stake in shares of Intuitive Surgical by 1.5% in the 3rd quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider’s stock valued at $3,456,223,000 after buying an additional 116,034 shares in the last quarter. Finally, Norges Bank bought a new position in shares of Intuitive Surgical during the 2nd quarter worth about $2,569,260,000. 83.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ISRG has been the subject of several recent analyst reports. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Wells Fargo & Company raised their price target on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Daiwa Capital Markets increased their target price on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. Finally, Evercore ISI lifted their price target on Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.